A Study of ABTL0812 in Pancreatic Cancer

Clinical trial NCT03417921 · SUSPENDED

Trial details

NCT number: NCT03417921
Sponsor: Ability Pharmaceuticals SL
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2021-04-26
Primary completion: 2023-04-26
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.